Cargando…
miR-378a-3p Participates in Metformin’s Mechanism of Action on C2C12 Cells under Hyperglycemia
Metformin is the most used biguanide drug for the treatment of type 2 diabetes mellitus. Despite being mostly known for its hepatic anti-gluconeogenic effect, it is also known to modulate microRNAs (miRNAs, miRs) associated with metabolic diseases. The latter mechanism could be relevant for better u...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827403/ https://www.ncbi.nlm.nih.gov/pubmed/33430391 http://dx.doi.org/10.3390/ijms22020541 |
_version_ | 1783640753903239168 |
---|---|
author | Machado, Ivo F. Teodoro, João S. Castela, Ana C. Palmeira, Carlos M. Rolo, Anabela P. |
author_facet | Machado, Ivo F. Teodoro, João S. Castela, Ana C. Palmeira, Carlos M. Rolo, Anabela P. |
author_sort | Machado, Ivo F. |
collection | PubMed |
description | Metformin is the most used biguanide drug for the treatment of type 2 diabetes mellitus. Despite being mostly known for its hepatic anti-gluconeogenic effect, it is also known to modulate microRNAs (miRNAs, miRs) associated with metabolic diseases. The latter mechanism could be relevant for better understanding metformin’s mechanisms underlying its biological effects. In the current work, we found that metformin increases miR-378a-3p expression (p < 0.002) in C2C12 myoblasts previously exposed to hyperglycemic conditions. While the inhibition of miR-378a-3p was shown to impair metformin’s effect in ATP production, PEPCK activity and the expression of Tfam. Finally, mitophagy, an autophagic process responsible for the selective degradation of mitochondria, was found to be induced by miR-378a-3p (p < 0.04). miR-378a-3p stimulated mitophagy through a process independent of sestrin-2 (SESN2), a stress-responsible protein that has been recently demonstrated to positively modulate mitophagy. Our findings provide novel insights into an alternative mechanism of action of metformin involving miR-378a-3, which can be used in the future for the development of improved therapeutic strategies against metabolic diseases. |
format | Online Article Text |
id | pubmed-7827403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78274032021-01-25 miR-378a-3p Participates in Metformin’s Mechanism of Action on C2C12 Cells under Hyperglycemia Machado, Ivo F. Teodoro, João S. Castela, Ana C. Palmeira, Carlos M. Rolo, Anabela P. Int J Mol Sci Article Metformin is the most used biguanide drug for the treatment of type 2 diabetes mellitus. Despite being mostly known for its hepatic anti-gluconeogenic effect, it is also known to modulate microRNAs (miRNAs, miRs) associated with metabolic diseases. The latter mechanism could be relevant for better understanding metformin’s mechanisms underlying its biological effects. In the current work, we found that metformin increases miR-378a-3p expression (p < 0.002) in C2C12 myoblasts previously exposed to hyperglycemic conditions. While the inhibition of miR-378a-3p was shown to impair metformin’s effect in ATP production, PEPCK activity and the expression of Tfam. Finally, mitophagy, an autophagic process responsible for the selective degradation of mitochondria, was found to be induced by miR-378a-3p (p < 0.04). miR-378a-3p stimulated mitophagy through a process independent of sestrin-2 (SESN2), a stress-responsible protein that has been recently demonstrated to positively modulate mitophagy. Our findings provide novel insights into an alternative mechanism of action of metformin involving miR-378a-3, which can be used in the future for the development of improved therapeutic strategies against metabolic diseases. MDPI 2021-01-07 /pmc/articles/PMC7827403/ /pubmed/33430391 http://dx.doi.org/10.3390/ijms22020541 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Machado, Ivo F. Teodoro, João S. Castela, Ana C. Palmeira, Carlos M. Rolo, Anabela P. miR-378a-3p Participates in Metformin’s Mechanism of Action on C2C12 Cells under Hyperglycemia |
title | miR-378a-3p Participates in Metformin’s Mechanism of Action on C2C12 Cells under Hyperglycemia |
title_full | miR-378a-3p Participates in Metformin’s Mechanism of Action on C2C12 Cells under Hyperglycemia |
title_fullStr | miR-378a-3p Participates in Metformin’s Mechanism of Action on C2C12 Cells under Hyperglycemia |
title_full_unstemmed | miR-378a-3p Participates in Metformin’s Mechanism of Action on C2C12 Cells under Hyperglycemia |
title_short | miR-378a-3p Participates in Metformin’s Mechanism of Action on C2C12 Cells under Hyperglycemia |
title_sort | mir-378a-3p participates in metformin’s mechanism of action on c2c12 cells under hyperglycemia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827403/ https://www.ncbi.nlm.nih.gov/pubmed/33430391 http://dx.doi.org/10.3390/ijms22020541 |
work_keys_str_mv | AT machadoivof mir378a3pparticipatesinmetforminsmechanismofactiononc2c12cellsunderhyperglycemia AT teodorojoaos mir378a3pparticipatesinmetforminsmechanismofactiononc2c12cellsunderhyperglycemia AT castelaanac mir378a3pparticipatesinmetforminsmechanismofactiononc2c12cellsunderhyperglycemia AT palmeiracarlosm mir378a3pparticipatesinmetforminsmechanismofactiononc2c12cellsunderhyperglycemia AT roloanabelap mir378a3pparticipatesinmetforminsmechanismofactiononc2c12cellsunderhyperglycemia |